haylaavo

GSKCONS

GSKCONS · NSE · inactive
10,732.60
+496.30 (+4.85%)
as of 15 Apr 2020 close
Open
10,310.00
High
10,850.00
Low
10,310.00
Prev close
10,236.30
52w high
11,296.30
08 Apr 2020
52w low
6,890.90
06 May 2019
VWAP
10,667.14
Delivery %
63.0%
of volume
Volume 2.00 L · turnover ₹213.05 Cr · NSE bhavcopy (official close) · history since 29 Jul 2003
Series
EQ
F&O
No
Status
Inactive since 02 Apr 2019

Formerly SMITKLBECH (until 29 Jul 2003). Earlier name: Smithkline Beecham Consumer Healthcare Ltd. (until 29 Jul 2003).

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 03:56 IST
  • 13 Mar 2020 12:25
    M&A

    GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange about Scheme of Arrangement

    PDF · -
  • 26 Feb 2020 18:58
    M&A

    Update on Scheme of amalgamation and arrangement between GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors

    PDF · -
  • 25 Apr 2019 14:53
    M&A

    GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange about Amalgamation/Merger Notice of Tribunal Convened Meeting of Unsecured Creditors of GlaxoSmithKline Consumer Healthcare Limited

    PDF · -
  • 25 Jan 2019 15:23
    M&A

    GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange�� regarding Approval of the Competition Commission of India to the proposed amalgamation of GlaxoSmithKline Consumer Healthcare Limited with Hindustan Unilever Limited. Disclosure under Regulation 30(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    PDF · -
  • 03 Dec 2018 14:19
    M&A

    GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that�� the Board of Directors of GlaxoSmithKline Consumer Healthcare Limited (the ��Company��) in its meeting held on December 03, 2018 considered and approved a scheme of amalgamation between the Company and Hindustan Unilever Limited (��HUL��), and their respective shareholders and creditors (��Scheme��) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries